Activity of new quinolones against ciprofloxacin-resistant staphylococci
about
Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.Mechanism of action of and resistance to quinolones.CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.In vitro antimicrobial susceptibilities of Nocardia species.Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infectionIn vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents.Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocciUpdate on clinical significance of coagulase-negative staphylococciExamination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistanceIn vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.New quinolones and gram-positive bacteria.In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.Assessment of the potential for microbial resistance to topical use of multiple antimicrobial agents.
P2860
Q33771929-DAD91E6E-4BE3-4DCE-BBCB-0A3532AF7C59Q34408434-4D88B03C-BA26-4F57-BCBB-D33AC44848BBQ34537953-2BC863BA-C7DE-45D1-8FA9-BBB528F055F7Q35115957-3DCA1C9C-994B-49C3-BDE6-F1726A9203EEQ35812628-D5D1FD37-CACC-43F6-B025-7FAC92E0F5D1Q35821605-0908F7C6-26D9-4DA9-B762-F1C82583BB2CQ35846160-B9661F55-0627-40D1-8E7C-4E001681D1CEQ35862887-25089B7E-286E-4B08-A20A-6ABBFC1FBF4FQ36640978-F6270E26-9758-4FBE-82F2-3B12213F2AD4Q39559760-9BBB006D-2804-46AE-AF45-3EF710256F0BQ40284828-240C9F89-8899-4D4E-9EAA-1228218151C8Q40284884-587430D9-EC17-4F4F-B1A0-C464EAC8F0A1Q41767493-5A58DFE8-ED32-410B-A417-C8C4E3C07ED1Q53800379-F6A2F12B-BABC-40B7-95DD-5D82D02D453DQ53846362-8829CF4A-9998-4AF8-A45A-30C1510C301C
P2860
Activity of new quinolones against ciprofloxacin-resistant staphylococci
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@ast
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@en
type
label
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@ast
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@en
prefLabel
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@ast
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@en
P2093
P2860
P356
P1476
Activity of new quinolones against ciprofloxacin-resistant staphylococci
@en
P2093
G J Forstall
J A Washington
P2860
P304
P356
10.1128/AAC.35.8.1679
P407
P577
1991-08-01T00:00:00Z